Hengrui Pharma Company Profile
✉ Email this page to a colleague
What is the competitive landscape for HENGRUI PHARMA, and what generic and branded alternatives to HENGRUI PHARMA drugs are available?
HENGRUI PHARMA has eighteen approved drugs.
Summary for Hengrui Pharma
| US Patents: | 0 |
| Tradenames: | 17 |
| Ingredients: | 16 |
| NDAs: | 18 |
Drugs and US Patents for Hengrui Pharma
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Hengrui Pharma | GADOBUTROL | gadobutrol | SOLUTION;INTRAVENOUS | 216081-003 | Nov 17, 2022 | AP | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ||||
| Hengrui Pharma | DEXMEDETOMIDINE HYDROCHLORIDE | dexmedetomidine hydrochloride | INJECTABLE;INJECTION | 209065-004 | Jun 12, 2020 | AP | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ||||
| Hengrui Pharma | OXALIPLATIN | oxaliplatin | INJECTABLE;INTRAVENOUS | 203869-001 | Jun 18, 2014 | AP | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ||||
| Hengrui Pharma | GADOTERATE MEGLUMINE | gadoterate meglumine | SOLUTION;INTRAVENOUS | 215304-002 | Apr 11, 2022 | AP | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ||||
| Hengrui Pharma | DEXMEDETOMIDINE HYDROCHLORIDE | dexmedetomidine hydrochloride | INJECTABLE;INJECTION | 209065-003 | Jun 12, 2020 | AP | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
